期刊文献+

SD大鼠糖尿病肾病模型构建的比较 被引量:10

Comparison different model construction methods of diabetic nephropathy SD rats
原文传递
导出
摘要 目的:探讨不同方法建立糖尿病肾病(diabetic nephropathy,DN)模型的差异,以确定建立糖尿病肾病大鼠模型的最佳方案。方法:清洁级健康雌性SD大鼠30只,随机分为3组,每组10只。A组大鼠单侧肾脏切除后腹腔注射链脲佐菌素(streptozotocin,STZ)55mg/kg,B组大鼠单侧肾脏结扎后腹腔注射STZ55mg/kg,C组为假手术对照组,注射等量的缓冲液。大鼠造模后从第1周开始每2周称体重,取血测血糖(Glu)、血肌酐(Scr)、总胆固醇(Chol)和甘油三酯(TG),收集尿测24h尿蛋白(24Upro)、尿肌酐(Ucr),并计算内生肌酐清除率(Ccr)。11周后,处死大鼠,取肾脏称重并进行肾脏病理。结果:A、B2组的成模周期相当,B组的存活率高于A组。结论:单侧肾脏结扎后再腹腔注射55mg/kgSTZ可以用来作为建立糖尿病肾病大鼠模型的理想方案。 Objective:To investigate the different model construction methods in diabetic nephropathy (DN) SD rats induced by streptozotocin(STZ) and establish the optimal plan. Methods:Thirty SD rats were randomly divided into 3 groups with 10 rats in each group. A group received intraperitoneal STZ after unilateral nephritic excision;B group received intraperitoneal STZ after unilateral nephritic ligation;C group(control group) received buffer solution only. The changes of body weight(BW),glucose(Glu),serum creatinine (Scr),cholesterol(Chol),triglyceride (TG)and 24-urine protein(24Upro),urine crea(Ucr)were detected every 2 weeks and creatinine clearance rate(Ccr) was calculated. After 11 weeks,the rats were sacrificed,and the kidneys were weighed and taken for pathological examination. Results:There was no significant difference in the model construction periods between the groups A and B. The survival rate of the group B is higher than that of the group A. Conclusion:STZ (55 mg / kg) intraperitoneal injection after unilateral nephritic ligation is the optimal method for inducing rat diabetic nephropathy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第8期1123-1128,共6页 Journal of Nanjing Medical University(Natural Sciences)
关键词 大鼠 链脲佐菌素 单侧肾脏切除 单侧肾脏结扎 糖尿病肾病 rat STZ uilateral nephritic excision unilateral nephritic ligation diabetic nephropathy
  • 相关文献

参考文献25

  • 1Wild S, Roglic G, Green A, et al. Global prevalence of diabetes estimates for the year 2000 and projections for 2030[J]. Diabetes Care,2004,27(5) : 1047-1053.
  • 2Cameron JS. The discovery of diabetic nephropathy:from small print to centre stage [J]. J Nephrol,2006, 19(10): 75-87.
  • 3Zlmmet P,Alberti KG,Shaw J. Global and societal implications of the diabetes epidemic [J]. Nature,2001,414 (6865) :782-787.
  • 4Su Kang KIM,Kyung-Hee JUNG,Byung-Cheol LEE. Protective effect of tanshinone IIA on the early stage of experimental diabetic nephropathy [J]. Biol Pharm Bull, 2009,32(2) : 220-224.
  • 5张丽娜,谢席胜,左川,樊均明.人参皂甙Rg1对糖尿病肾病大鼠TNF-α、MCP-1表达的影响[J].四川大学学报(医学版),2009,40(3):466-471. 被引量:39
  • 6Kuhad A, Sachdeva AK, Chopra K. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol[J]. J Agric Food Chem,2009,57 (14) :6123-6128.
  • 7Kuhad A,Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway [ J ]. Life Sci, 2009,84(9-10) : 296-301.
  • 8Kang MJ,Ingram A,LY H,et al. Effects of diabetes and hypertension on glomerular transforming growth factorbeta receptor expression [J]. Kidney Int,2000,58 (4) : 1677- 1685.
  • 9王新,唐方.单侧肾脏结扎术+链脲佐菌素诱导糖尿病肾病动物模型建立方法的探讨[J].天津医科大学学报,2006,12(1):18-20. 被引量:8
  • 10Lee TN,Albom WE,Knierman MD,et al. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl- beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity [J]. Biochem, Pharmacol, 2006,72(6) :710-718.

二级参考文献39

共引文献255

同被引文献127

引证文献10

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部